Related Experiment Video
Updated: Feb 7, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder
Patrizia Bonadonna1, Luigi Scaffidi2
1Allergy Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Piazzale Stefani 1, Verona 37126, Italy; Multidisciplinary Outpatients Clinic for Mastocytosis (GISM), Azienda Ospedaliera Universitaria Integrata di Verona, Piazzale Stefani 1, Verona 37126, Italy.
Up to 7% of adults with Hymenoptera venom allergy have clonal mast cell disease. Diagnosis requires vigilance, as normal tryptase levels don't rule out mastocytosis, necessitating lifelong immunotherapy.
Area of Science:
- Allergy and Immunology
- Hematology
Background:
- Hymenoptera venom allergy affects adults, with a subset experiencing clonal mast cell disease.
- Clonal mast cell disease in this context presents specific clinical features.
Purpose of the Study:
- To highlight the association between Hymenoptera venom allergy and clonal mast cell disease.
- To describe the clinical characteristics of patients with both conditions.
- To emphasize diagnostic considerations and therapeutic implications.
Main Methods:
- Retrospective analysis of adult patients with Hymenoptera venom allergy.
- Clinical data review focusing on demographics, symptoms, and laboratory findings.
- Evaluation of diagnostic criteria for mast cell disease.
Main Results:
- Approximately 7% of adult Hymenoptera venom allergy patients may have clonal mast cell disease.
- Affected patients are often male, lacking skin lesions.
- Anaphylaxis commonly presents with hypotension and syncope, without urticaria or angioedema.
- Normal tryptase levels do not exclude mastocytosis.
Conclusions:
- Clonal mast cell disease is an important consideration in Hymenoptera venom allergy.
- Specific clinical patterns can suggest mast cell disease even with normal tryptase.
- Diagnosis mandates lifelong venom immunotherapy for managing allergy and preventing severe reactions.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Intrinsically Disordered Proteins
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

